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Background: The gut microbiota is critical for intestinal homeostasis. Recent studies have revealed the links
between different types of dysbiosis and diseases inside and outside the intestine. Environmental exposure to
pollutants (such as heavy metals) can also impair various physiological functions for good health. Here, we studied
the impact of up to 8 weeks of oral lead and cadmium ingestion on the composition of the murine intestinal
microbiome.
Results: Pyrosequencing of 16S RNA sequences revealed minor but specific changes in bacterial commensal
communities (at both family and genus levels) following oral exposure to the heavy metals, with notably low
numbers of Lachnospiraceae and high numbers levels of Lactobacillaceae and Erysipelotrichaceacae (mainly due to
changes in Turicibacter spp), relative to control animals.
Conclusions: Non-absorbed heavy metals have a direct impact on the gut microbiota. In turn, this may impact the
alimentary tract and overall gut homeostasis. Our results may enable more accurate assessment of the risk of
intestinal disease associated with heavy metal ingestion.
Keywords: Heavy metal exposure, Gut microbiota, Mice, 16S pyrosequencing, Turicibacter, Denaturing gradient gel
electrophoresis (DGGE)Background
Chronic ingestion of environmental heavy metals (HMs,
such as lead (Pb) and cadmium (Cd)) is associated with
the occurrence of various diseases. The underlying mech-
anism is thought to be related to excessive local and
systemic oxidative stress or deregulation of immune re-
sponses. Intestinal absorption of HMs leads to accumula-
tion in specific target organs, with severe detrimental
effects on human health. However, high concentrations of
non-absorbed HMs remain in the gut microenvironment,
where they may have a direct impact on the gut ecosystem
and its overall physiology [1,2]. The gut microbiota has
been described as a complex “hidden” organ, which plays
a key role in the maintenance of health; hence, the pres-
ence or absence of specific species can be essential for* Correspondence: benoit.foligne@ibl.fr
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stated.maintaining homeostasis both inside and outside the in-
testinal tract [3,4].
The gastrointestinal epithelium has several essential
functions: constituting a physical barrier, ensuring mu-
cosal immune responses and excluding or detoxifying
harmful intestinal content. These processes are highly
influenced by the microbiota via a complex interplay with
the host [5-7]. Disturbance of the microbiota (dysbiosis) is
associated with an increased risk of developing inflamma-
tory diseases, allergic diseases and metabolic disorders;
hence, it is of the utmost importance to understand micro-
biotal variability if we are to better understand disease
states [8,9]. The most studied factors affecting microbiota
composition are age, genetic background, diet and anti-
biotic consumption [10]. It has also been postulated that
exposure to xenobiotic agents from the environment is an
important factor shaping the gut microbiota. However,
little attention has been given to the potential impact
of bioavailable HMs on the commensal microbiota and
intestinal homeostasis. We thus sought to characterize
possible impact of environmental Pb and Cd on the mi-
crobial ecosystem in mice, in order to better understandLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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and pathogenesis of gastrointestinal disorders in humans.
Methods
Animals and ethics statement
Twenty-five Balb/C female mice (aged 6 weeks on arrival)
were obtained from Charles River (Saint-Germain-sur-
l’Arbresle, France). The animals were randomly divided
into groups of five and housed in a controlled environ-
ment (a temperature of 22°C, a 12 h/12 h light/dark cycle
and with ad libitum access to food and water). All animal
experiments were performed according to the guidelines
of the Institut Pasteur de Lille Animal Care and Use
Committee and in compliance with the Amsterdam
Protocol on Animal Protection and Welfare and the
Directive 86/609/EEC on the Protection of Animals
Used for Experimental and Other Scientific Purposes
(updated in the Council of Europe’s Appendix A).
The animal work was also compliant with French le-
gislation (the French Act 87–848, dated 19-10-1987) and
the European Communities Amendment of Cruelty to
Animals Act 1976. The study’s objectives and procedures
were approved by the Ethic and Welfare Committee for
Experiments on Animals in France’s Nord-Pas-de-Calais
region (approval number: 04/2011).
Animal exposure procedures and experimental set-up
Mice were exposed to doses of either Cd (20 or 100 ppm)
or Pb (100 or 500 ppm), where ppm correspond to mg
L-1. The metals were administered continuously for
8 weeks by spiking the animals’ drinking water with
CdCl2 or PbCl2 solution, as previously described [11].
In order to cover both “environmentally relevant (low)”
and “critical” doses of Cd exposure and to mimic Pb poi-
soning, the HM doses were selected according to the
respective “lowest observed adverse effect” level (LOAEL)
for chronic exposure in rodents. Control animals received
water with no added CdCl2 or PbCl2. Fecal pellets and
cecal content were collected in tubes and weighed.
Samples were snap-frozen and then stored at −80°C until
nucleic acid extraction was performed, as described previ-
ously [12].
DNA extraction and PCR amplification
16S rRNA genes were amplified using the PCR primers
[13], which target the V5 and V6 hypervariable regions.
The forward primer contained the sequence of the
Titanium A adaptor (5′-CCATCTCATCCCTGCGTG
TCTCCGACTCAG-3′) and a barcode sequence. The
reverse primer contained the sequence of Titanium B
adaptor primer B: (5′-CCTATCCCCTGTGTGCCTT
G-3′). For each sample, a PCR mix of 100 μL contained
1 × PCR buffer, 2 U of KAPA HiFi Hotstart polymerase
blend and dNTPs (Kapabiosystems, Clinisciences, Naterre,France), 300 nM primers (Eurogentec, Liège, Belgium),
and 60 ng per g DNA. Thermal cycling consisted of initial
denaturation at 95°C for 5 min, followed by 25 cycles of
denaturation at 98°C for 20 s, annealing at 56°C for 40 s
and extension at 72°C for 20 s, plus final extension at 72°C
for 5 min. Amplicons were visualized on 1% agarose. Gels
were stained with GelGreen Nucleic Acid gel stain in 1x
Tris-acetate-EDTA (TAE) buffer and then cleaned with
Wizard SV Gel and PCR Clean-up System (Promega,
Charbonnieres les Bains, France), according to the manu-
facturer’s instructions.
Amplicon quantitation, pooling, and pyrosequencing
Amplicon DNA concentrations were determined using
the Quant-iT PicoGreen dsDNA reagent and kit (Life
Tech, Carlsbad, CA) following the manufacturer’s in-
structions. Assays were carried out using 2 μL of cleaned
PCR product in a total reaction volume of 200 μL in
black, 96-well microtiter plates. Following quantitation,
cleaned amplicons were combined in equimolar ratios in
a single tube .The final pool of DNA was eluted in 100 μL
of nuclease-free water and purified using an Agencourt
Ampure XP Purification Systems, according to the manu-
facturer’s instructions (Agencourt Biosciences Corporation-
Beckman Coulter, Beverly, MA) and then resuspended in
100 μL of TAE 1x. The concentration of the purified pooled
DNA was determined using the Quant-iT PicoGreen
dsDNA reagent and kit (Life Tech, Carlsbad, CA), accord-
ing to the manufacturer’s instructions. Pyrosequencing was
carried out using primer A on a 454 Life Sciences Genome
Sequencer FLX instrument (Roche, Branford, CT) following
titanium chemistry.
16S rRNA data analysis
The sequences were assigned to samples as a function of
their sample-specific barcodes. The sequences were then
checked for the following criteria [14]: (i) an almost per-
fect match with the barcode and primers; (ii) at least 240
nucleotides in length (not including barcodes and
primers); and (iii) no more than two undetermined bases
(denoted by N). By “an almost perfect match”, we mean
that one mismatch/deletion/insertion per barcode or per
primer was allowed. Each pyrosequenced dataset that
passed quality control was assigned to a family with the
RDP classifier (version 2.1, http://rdp.cme.msu.edu) with
a confidence threshold > 80%. The Chao richness esti-
mate was calculated with the Mothur software package
(for more details, see http://www.mothur.org/wiki/Chao).
Denaturing gradient gel electrophoresis (DGGE)
The variable V3 region of the 16S rRNA gene was ampli-
fied using the universal bacterial primers F357-GC and
R518 [15,16]. The PCR and temperature program have
been described elsewhere [17]. The resulting 16S rRNA
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(the D-Code System from Bio-Rad, Nazareth, Belgium)
using 35% to 70% denaturing gels, as previously described
[16]. Each lane received 30 μl of PCR product and electro-
phoresis was performed at 70 V for 990 min. Next, the
DGGE gels were stained for 30 min with 1 X SYBR Gold
nucleic acid gel stain (S-11494; Invitrogen, Merelbeke,
Belgium) in 1 X TAE buffer (Bio-Rad), and the band pro-
files were digitized and visualized with a charge-coupled
device (CCD) camera and Quantity One software (Bio-
Rad). Every fifth or sixth lane contains a reference sample
(containing the V3-16S rRNA amplicons of a taxonomic-
ally well-characterized strain for each of 12 bacterial
species) and fingerprint profiles were normalized using
BioNumerics software (version 5.10, Applied Maths, Sint-
Martens-Latem, Belgium).
Statistics and data analysis
All statistical analyses were performed by comparing
experimental groups with the control group. A non-
parametric one–way analysis of variance, Mann–Whitney
U-tests or Student’s t tests were used as appropriate. Bac-
terial count data are presented as the mean ± standard
error of the mean (SEM). The threshold for statistical sig-
nificance was set to p < 0.05.
Results and discussion
In the present study, groups of wild-type mice under-
went up to of 8 weeks continuous exposure to CdCl2 (20Cecal flora
CTL Cd 20 Pb 100M
Figure 1 DGGE profiles revealed microbial diversity in the cecum con
salts via their drinking water. The figure shows DGGE gels of the V5-V6 h
in the cecum and the feces of 4 mice treated (or not) with 20 mg L-1 (ppmor 100 ppm) or PbCl2 (100 or 500 ppm) administered in
their drinking water. In an earlier study, these HM levels
were sub-toxic and not associated with hepatotoxicity or
changes in behavior, organ weights (liver, spleen and kid-
neys), body weight or overall growth (when compared
with regular water-treated mice, [11]. Furthermore, none
of the HM treatments had a detectable impact on our
animals’ food intake, stool consistency or gut motility.
Indeed, this was demonstrated by providing oral exogen-
ous food-grade microorganisms (such as yeasts and lac-
tic bacteria) as feces markers. All the animals exhibited
similar transit times and persistence parameters (data
not shown).
We measured the microbial communities’ profiles in
feces and cecal content. On the basis of the DGGE
results, an 8-week treatment with either Cd or Pb did
not significantly modify the murine microbiota at ei-
ther sampling site (Figure 1). A discriminant analysis
of band classes (performed with Bionumerics soft-
ware) enabled us to distinguish between fecal and co-
lonic samples (Figure 2) and between control samples
and HM-treated samples but did not pinpoint sys-
tematic differences between Pb and Cd treatments or
between low and high concentrations of the HMs
(results not shown). This finding contrasts with a re-
cent report in which oral Cd had harmful effects on
the viability of some components of the mouse
microbiota [18]. This disparity might be explained by
the fact that Fazeli and coworkers used restrictiveFecal flora
CTL Cd 20 Pb 100M
tent and fecal pellets of mice exposed for 8 weeks to Cd and Pb
ypervariable 16S rDNA region, illustrating the microbiota’s composition
) of Cd or 100 mg L-1 (ppm) of Pb.
Cecal flora Fecal flora
CTL  Cd 20 Pb 100
Figure 2 An unweighted pair group method with arithmetic
mean tree of the same gels. Pairwise similarities were calculated
with BioNumerics software (version 6.6.4), using a Dice coefficient
with 0% optimization, 0.3664% fixed tolerance, exclusion of
uncertain bands and no relaxed doublet matching, fuzzy logic or
area sensitivity.
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lar approach.
A more in-depth analysis of the cecal and fecal
microbiome was carried out via 454 pyrosequencing
of the V5-V6 region of the 16S rRNA (Table 1, Figures 3
and 4). We generated a dataset consisting of 197,143 fil-
tered, high-quality 16S rRNA gene sequences (mean ± SD
number of sequences per sample: 11,596 ± 6060). With
operational taxonomic unit (OTU) cut-offs of 0.03, 0.05
or 0.10, the samples from the Cd, Pb and control groups
did not differ significantly in terms of microbial richness
(as estimated by the Chao richness index) or biodiversity
(assessed by a nonparametric Shannon index). With an
OTU cut-off of 0.03, the mean number of clusters was
1244 ± 381. The abundance of the two major phyla (the
Firmicutes and Bacteroidetes) was similar in all three
groups, whereas there were few Actinobacteria (Figure 3).
In contrast, treatment with the two HMs was associ-
ated with a change in the composition of the colonic
microbiota at both the family and genus levels. In
fact, eight weeks of oral Cd or Pb treatment caused
small but statistically significant differences in num-
bers of Prevotellaceae and Clostridiaceae (especially in
the feces). Significant differences (p < 0.05) in the rela-
tive abundance of several other families in both cecal
and fecal samples were observed, with low numbers
of Lachnospiraceae and high numbers of Lactobacilla-
ceae and Erysipelotrichaceae in the HM-treated groups(Figure 4A). Within the Erysipelotrichaceae family, num-
bers of Turicibacter (Figure 4B), coprococci, streptococci,
Blautia, Barneselia and Allistipes were higher in HM-
treated groups than in controls. In general, we observed
lower genus diversity in the HM-treated groups. Low
bacterial diversity and low number of Lachnospiraceae
have been linked to intestinal inflammation and consid-
ered as a predisposition to colitis [19,20]. Whether changes
in Lachnospiraceae, Lactobacillaceae and Erysipelotricha-
ceae are consistently linked with inflammation remains
to be established. However, the frequent literature re-
ports on changes in the abundance of these groups in
the mouse microbiome indicate that these groups are
more sensitive to external factors than other, less abun-
dant groups are. However, cautious interpretation is ne-
cessary because of the low family-level resolution of
metagenomics, which prevents reliable microbial com-
munity analyses under in inflammatory conditions, for
example [21].
The genus Turicibacter was previously detected in the
ileal pouch of an ulcerative colitis patient [22], in human
appendicitis [23] and in infectious states in piglets. Inter-
estingly, high levels of Turicibacter were observed in
mice fed an iron-free diet (in which these bacteria might
favor anti-inflammatory effects) [24] and in colitis-resistant
CD8-knock-out mice (where it is potentially involved in
the anti-inflammatory phenotype) [25]. The ongoing se-
quencing of several Turicibacter spp genomes will
hopefully clarify their function as part of the micro-
biota and elucidate their role(s) in the interaction be-
tween HM exposure and inflammation [26]. Lastly, the
lactobacilli’s apparent ability to tolerate HMs might be
helpful for bioremediation purposes, since some mi-
croorganisms can bind labile metal ions and remove
them from the environment [27]. In theory, HM-
resistant, innocuous strains with anti-oxidant and
anti-inflammatory properties could be used as probio-
tics by combining their chelating properties with tar-
geted treatment of the xenobiotics’ harmful effects on
the host’s microbiota [28,29].
Laboratory mice have a less complex gut microbiota
than humans and there are only slight mouse-to-mouse
variations when groups of individuals are housed to-
gether. Nevertheless, HM-associated differences in the
microbiota were observed in all individual, exposed mice
(data not shown). Our DGGE and metagenomics results
confirmed a clear link between ingestion of HMs and
the composition of the gut microbiota. The marked,
environmentally-induced alteration in the gut microbiota
also suggests a link between HM exposure and inflam-
mation. However, the functional classification of groups
of bacteria as “predisposing”, “colitogenic” or even “pro-
tective” is hotly debated and difficult to investigate [23].
Besides producing quantitative and qualitative changes
Table 1 Relative distributions of bacterial phylotypes, families and genera in (i) the cecum content of mice orally
exposed for 8 weeks to Cd (20 or 100 ppm) or Pb (100 or 500 ppm) salts and (ii) the fecal pellets for mice orally
exposed for 8 weeks to Cd (20 ppm) or Pb (100 ppm)
Phylum Cd0Pb0 Cd20 Cd100 Pb100 Pb500
Cecal content
Actinobacteria 0.25% 0.59% 1.19% 2.27% 0.25%
(range) (0.11-0.40) (0.16-1.30) (0.36-1.84) (0.11-5.39) (0.10-0.40)
SEM 0.049 0.210 0.272 1.113 0.161
P value - 0.0775 0.0045 0.0537 0.478
Bacteroidetes 1.9% 2.58% 1.60% 1.47% 1.36%
(range) s(1.29-2.28) (0.35-7.66) (0.31-4.97) (0.30-3.36) (0.8-2.40)
SEM 0.183 1.328 0.854 0.612 0.3
P value - 0.3131 0.3697 0.2578 0.0869
Firmicutes 97.8% 96.77% 97.2% 96.24% 98.36%
(range) (97.4-98.4) (92.0-99.3) (93.1-98.8) (91.1-99.6) (97.9-99.0)
SEM 0.187 1.297 1.037 1.739 0.272
P value - 0.2269 0.2916 0.1986 0.1755
Fecal pellet
Actinobacteria 0.30% 0.39% 0.24%
(range) (0.18-0.50) (0.13-0.65) (0.08-0.42)
SEM 0.053 0.089 0.058
P value - 0.2304 0.2188
Bacteroidetes 34.4% 38.8% 35.65%
(range) (12.5-50.8) (30.1-7.5) (22.4-51.5)
SEM 6.56 10.84 8.65
P value - 0.3670 0.4553
Firmicutes 64.7% 60.44% 63.85%
(range) (48.2-71.3) (47.5-90.9) (38.2-77.5)
SEM 6.73 10.86 8.72
P value - 0.3736 0.4701
Family Cd0Pb0 Cd20 Cd100 Pb100 Pb500
Cecal content
Lachnospiraceae 72.6% 53.17% 25.9% 43.7% 67.5%
(range) (33.2-88.3) (26.8-76.6) (10.3-28.5) (27.1-61.4) (59.1-75.0)
SEM 10.01 9.24 4.15 6.09 2.62
P value - 0.037 0.0081 0.0378 0.05859
Lactobacillaceae 22.34% 38.20% 54.68% 38.24% 26.1%
(range) (5.6-64.9) (19.01-60.6) (41.6-81.6) (28.7-67.1) (19.2-32.1)
SEM 10.88 8.54 7.06 7.26 2.09
P value - 0.05859 0.0379 0.0379 0.05859
Ruminococcaceae 1.82% 2.15% 2.64% 2.15% 1.14%
(range) (0.72-3.01) (0.76-5.91) (0.81-7.21) (0.63-3.22) (0.58-1.67)
SEM 0.442 0.836 0.876 0.934 0.939
P value - 0.3804 0.2627 0.3106 0.0997
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Table 1 Relative distributions of bacterial phylotypes, families and genera in (i) the cecum content of mice orally
exposed for 8 weeks to Cd (20 or 100 ppm) or Pb (100 or 500 ppm) salts and (ii) the fecal pellets for mice orally
exposed for 8 weeks to Cd (20 ppm) or Pb (100 ppm) (Continued)
Porphyromonadaceae 0.42% 0.63% 0.42% 0.49% 0.41%
(range) (0.0-1.25) (0.0-2.24) (0.0-1.41) (0.0-1.65) (0.05-1.24)
SEM 0.228 0.438 0.433 0.415 0.411
P value - 0.3152 0.4774 0.4139 0.0641
Rikenellaceae 0.51% 0.42% 0.27% 0.21% 0.26%
(range) (0.0-1.32) (0.0-1.32) (0.0-0.92) (0.0-0.6)
(0.0-0.47)
SEM 0.250 0.245 0.259 0.174 0.174
P value - 0.3883 0.2216 0.1564 0.1800
Coriobacteriaceae 0.49% 1.19% 2.38% 4.57% 0.36%
(range) (0.2-0.76) (0.23-2.6) (0.69-4.35) (0.2-11.75) (0.1-0.51)
SEM 0.111 0.0939 0.107 0.433 0.138
P value - 0.1736 0.01414 0.0250 0.3
Streptococcaceae 0.3% 0.14% 0.15% 0.24% 0.04%
(range) (0.0-0.50) (0.05-0.3) (0.0-0.66) (0–0.75) (0–0.1)
SEM 0.102 0.0239 0.0983 0.0894 0.0581
P value - 0.0901 0.1905 0.3711 0.0164
Erysipelotrichaceae 0.1% 2.32% 12.98% 6.89% 3.6%
(range) (0.0-0.24) (0.42-8.02) (3.82-28.12) (2.13-14) (1.73-6.05)
SEM 0.044 0.232 0.219 0.268 0.02236
P value - 0.0182 0.0096 0.0096 0.00051
Family Cd0Pb0 Cd20 Pb100
Fecal pellet
Lachnospiraceae 37.36% 23.67% 12.55%
(range) (18.8-86.9) 1.77-82.9) (3.52-26.6)
SEM 12.81 14.14 17.28
P value - 0.0453 0.023
Lactobacillaceae 32.99% 42.77% 50.88%
(range) (10.3-51.2) (4.49-67.1) (25.1-65.6)
SEM 8.58 8.87 10.02
P value - 0.2782 0.1121
Ruminococcaceae 1.70% 1.4% 0.83%
(range) (0.24-3.46) (0.08-4.58) (0.11-1.61)
SEM 0.65 0.65 0.86
P value - 0.3916 0.1275
Porphyromonadaceae 11.14% 13.01% 12%
(range) (3.46-16.25) (1.60-22.04) (4.88-19.6)
SEM 2.22 3.11 3.84
P value - 0.3447 0.4075
Rikenellaceae 8.36% 4.99% 5.82%
(range) (5.71-14.18) (1.93-16.07) (0.45-18.5)
SEM 1.92 2.47 2.87
P value - 0.1736 0.2626
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Table 1 Relative distributions of bacterial phylotypes, families and genera in (i) the cecum content of mice orally
exposed for 8 weeks to Cd (20 or 100 ppm) or Pb (100 or 500 ppm) salts and (ii) the fecal pellets for mice orally
exposed for 8 weeks to Cd (20 ppm) or Pb (100 ppm) (Continued)
Coriobacteriaceae 0.68% 0.67% 0.41%
(range) (0.03-0.99) (0.32-1.32) (0.16-0.67)
SEM 0.137 0.114 0.159
P value - 0.4841 0.0677
Streptococcaceae 0.27% 0.26% 0.20%
(range) (0.0-0.68) (0.02-0.69) (0–0.36)
SEM 0.127 0.129 0.09
P value - 0.4969 0.3060
Erysipelotrichaceae 0.33% 4.05% 6.56%
(range) (0.0-0.89) (0.48-15.53) (0.44-20.7)
SEM 0.158 0.399 0.4033
P value - 0.0585 0.0107
Prevotellaceae 0.14% 1.06% 0.75%
(range) (0.0-0.25) (0.08-4.14) (0.11-1.22)
SEM 0.058 0.806 0.812
P value - 0.1345 0.049
Clostridiaceae 0.00% 0.675% 1.55%
(range) (0.0-0.00) (0.0-2.17) (0.0-3.06)
SEM 0.0 0.094 0.0940
P value - 0.0628 0.0086
Genus Cd0Pb0 Cd20 Cd100 Pb100 Pb500
Cecal content
Lactobacillus 75.28 84.57% 77.4% 74.8% 83.82%
(range) (60–98.9) (68–91.11) (57.6-93.6) (54.1-90.6) (80.4-89.3)
SEM 7.554 4.419 5.97 7.741 1.589
P value - 0.2229 0.1248 0.1234 0.1503
Blautia 5.39% 2.82% 0.36% 4.90% 0.78%
(range) (0–12.6) (0.45-8.8) (0–0.97) (0–9.2) (0.3-1.22)
SEM 2.58 1.526 0.176 1.990 0.165
P value - 0.2456 0.1085 0.1136 0.2036
Coprococcus 3.49% 3.06% 0.46% 1.65% 0.64%
(range) (0–7.95) (0.22-6.49) (0.14-0.73) (0.7-3.62) (0.32-1.2)
SEM 1.651 1.172 0.110 0.521 0.151
P value - 0.1874 0.2086 0.2677 0.2757
Alistipes 3.42% 1.40% 0.41% 0.40% 0.74%
(range) (0.0-12.5)(0.0-4.0) (0.0-1.49) (0.0-1.16) (0.0-1.34)
SEM 2.40 0.725 0.273 0.232 0.221
P value - 0.2084 0.0439 0.4421 0.0461
Steptococcus 2.84% 0.35% 0.24% 0.47% 0.11%
(range) (0.0-6.67) (0.11-0.80) (0.0-1.05) (0.0-1.45) (0.0-0.24)
SEM 1.235 0.132 0.204 0.274 0.0514
P value - 0.4189 0.0522 0.1590 0.0616
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Table 1 Relative distributions of bacterial phylotypes, families and genera in (i) the cecum content of mice orally
exposed for 8 weeks to Cd (20 or 100 ppm) or Pb (100 or 500 ppm) salts and (ii) the fecal pellets for mice orally
exposed for 8 weeks to Cd (20 ppm) or Pb (100 ppm) (Continued)
Barnesiella 1.56% 0.34% 0.44% 0.66% 0.72%
(range) (0.0-6.67) (0.0-0.8) (0.0-1.35) (0.0-2.6) (0.0-2.27)
SEM 1.295 0.152 0.244 0.503 0.404
P value - 0.1598 0.4157 0.4842 0.1505
Bacteroides 0.95% 0.44% 0.09% 0.11% 0.36%
(range) (0.0-3.33) (0.0-1.6) (0.0-0.37) (0–0.54) (0–1.29)
SEM 0.631 0.292 0.071 0.108 0.236
P value - 0.0401 0.0356 0.0489 0.0229
Turicibacter 0.28% 4.02% 19.63% 14.34% 11.32%
(range) (0.0-1.15) (0.76-11.8) (4.48-41.3) (3.09-22.15) (6.37-15.4)
SEM 0.222 1.987 6.566 4.599 1.749
P value - 0.0492 0.0092 0.0078 0.0001
Genus Cd0Pb0 Cd20 Pb100
Fecal pellet
Lactobacillus 49.31% 58.0% 63.07%
(range) (8.96-73.18) (22.4-88.4) (34.4-82.9)
SEM 10.71 12.14 11.67
P value - 0.3032 0.2053
Blautia 0.73% 0.75% 0.28%
(range) (0.0-2.99) (0.0-3.28) (0.0-0.64)
SEM 0.570 0.634 0.143
P value - 0.4873 0.2331
Coprococcus 1.61% 0.83% 0.14%
(range) (0.0-5.97) (0.0-3.48) (0.0-0.32)
SEM 1.101 0.664 0.065
P value - 0.2795 0.1091
Alistipes 17.5% 8.47% 7.20%
(range) (7.2-29.8) (2.0-19.3) (0.43-24.5)
SEM 3.871 3.822 4.454
P value - 0.0678 0.0495
Steptococcus 0.50% 0.38% 0.28%
(range) (0.0-1.44) (0.1-0.87) (0.0-0.5)
SEM 0.263 0.152 0.094
P value - 0.3494 0.2254
Barnesiella 14.18% 9.13% 7.38%
(range) (6.8-25.3) (5.12-16.7) (2.4-11.8)
SEM 3.049 2.216 1.711
P value - 0.1086 0.0438
Bacteroides 11.17% 12.32% 10.46%
(range) (4.7-19.6) (2.08-39.9) (3.76-24.8)
SEM 3.175 7.419 4.364
P value - 0.4448 0.4492
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Table 1 Relative distributions of bacterial phylotypes, families and genera in (i) the cecum content of mice orally
exposed for 8 weeks to Cd (20 or 100 ppm) or Pb (100 or 500 ppm) salts and (ii) the fecal pellets for mice orally
exposed for 8 weeks to Cd (20 ppm) or Pb (100 ppm) (Continued)
Turicibacter 0.75% 4.81% 8.71%
(range) (0.0-1.49) (0.82-17.6) (2.84-28.24)
SEM 0.307 3.236 4.996
P value - 0.0483 0.0281
Data are expressed as the mean, range and SEM percentage abundance of the total assignment (n = 5 animals per group) and the corresponding p value is given
in italics. The threshold for statistical significance was set to p < 0.05.
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directly) intestinal homeostasis through their many local
effects (on the epithelia mucosa) and systemic effects.
Indeed, we previously reported that chronic ingestion of
Cd and Pb induced (i) anemia and tissue iron loss from
tissues, (ii) slight but consistent changes in the expres-
sion of transport-related genes, (iii) the small intestine
and colon’s oxidative and inflammatory status and (iv)
genotoxicity [11]. It is difficult to predict the net inflam-
matory balance in this context, since both harmful and
adaptive events occur together. We also recently empha-
sized the key role of the microbiota in the process of
HM absorption and dissemination throughout the body
- illustrating the complex metal-microbe-host interplay
that operates [30]. Our present ecotoxicological results
complement that first attempt to identify the impact of
HMs on the gut’s microbial ecology. This is in line with
the need to develop a more comprehensive view of




Control Cadmium20 ppm 
Fecal flora
Control Cadmium20 ppm 
Figure 3 Distribution of bacterial phylotypes in the cecum content an
100 ppm) or Pb (100 or 500 ppm) salts via their drinking water. 16S r
quencing. Data are expressed as the mean percentage abundance of the t
data, most of the bacteria in untreated (control) mice belonged to Firmicuto the mere entry of xenobiotics into the body but
also takes account of inflammation, oxidative stress,
other gut flora, metabolic processes and a continually
fluctuating chemical environment. Defining this type
of integrated “exposome” may provide a way of caus-
ally linking long-term exposure to the occurrence of
chronic disease [31].
Conclusions
Non-absorbed heavy metals have a direct impact on the
gut microbiota. In turn, this may impact the alimentary
tract and overall gut homeostasis. Our results may en-
able more accurate assessment of the risk of intestinal
disease associated with heavy metal ingestion. Further
studies are needed to understand the complex crosstalk
between the gut microbiota and the host, interpret the
clinical consequences of exposure to xenobiotics and as-
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Figure 4 Distribution of bacterial subgroups in the cecum content and fecal pellets of mice exposed for 8 weeks to Cd (20 or 100 mg L-1)
or Pb (100 or 500 mg L-1) salts via their drinking water. (A) Family-level and (B) genus-level. 16S rRNA-base analyses were derived from
454/Roche multitag pyrosequencing. Data are expressed as the mean percentage abundance (n = 5 animals per group). Only operational
taxonomic units (OTU’s) present in dominant families (> 0.1%) were considered. *: p < 0.05 and **: p < 0.01: significantly different from the control
group (water with no added Cd or Pb) for the corresponding taxa. The color code is defined in the inset on the right of the Figure.
Breton et al. BMC Pharmacology and Toxicology 2013, 14:62 Page 10 of 11
http://www.biomedcentral.com/bmcpharmacoltoxicol/2050-6511/14/1/62Competing interests
None of all authors have conflicts of interest to declare.Authors’ contributions
BF and BP: study conception and design and drafting of the manuscript;
BF, JB, SM, EDB and PVD: data acquisition; BF, SM, PVD and BP: data analysis
and interpretation. All authors read and approved the final manuscript.Acknowledgments
This study was funded by a grant from the French National Research Agency
(ANR-09-CES-016: Mélodie-Reve). The authors thank Dr Fabienne Jean for her
assistance with project management and Humphrey Bihain-Tasseur for
valuable advice.Author details
1Bactéries Lactiques & Immunité des Muqueuses, Centre d‘Infection et
d’Immunité de Lille, Institut Pasteur de Lille, U1019, UMR 8204, Université
Lille Nord de France, 1 rue du Pr Calmette, Lille cedex BP 245, F-59019,
France. 2DNAVision SA, avenue George Lemaitre 25, Charleroi B-6041,
Belgium. 3Laboratory of Microbiology, Faculty of Sciences, Ledeganckstraat
35, Ghent B-9000, Belgium.
Received: 13 October 2013 Accepted: 4 December 2013
Published: 11 December 2013References
1. Zalups RK, Ahmad S: Molecular handling of cadmium in transporting
epithelia. Toxicol Appl Pharmacol 2003, 186(3):163–188.
Breton et al. BMC Pharmacology and Toxicology 2013, 14:62 Page 11 of 11
http://www.biomedcentral.com/bmcpharmacoltoxicol/2050-6511/14/1/622. James HM, Hilburn ME, Blair JA: Effects of meals and meal times on
uptake of lead from the gastrointestinal tract in humans. Hum Toxicol
1985, 4(4):401–407.
3. O’Hara AM, Shanahan F: The gut flora as a forgotten organ. EMBO 2006,
7(7):688–693. Rep.
4. Sekirov I, Russell SL, Antunes LC, Finlay BB: Gut microbiota in health and
disease. Physiol Rev 2010, 90(3):859–904.
5. Leser TD, Molbak L: Better living through microbial action: the benefits of
the mammalian gastrointestinal microbiota on the host. Environ Microbiol
2009, 11(9):2194–2206.
6. Nicholson JK, Holmes E, Wilson ID: Gut microorganisms, mammalian
metabolism and personalized health care. Nat Rev Microbiol 2005,
3(5):431–438.
7. Claus SP, Ellero SL, Berger B, Krause L, Bruttin A, Molina J, Paris A, Want EJ,
de Waziers I, Cloarec O, et al: Colonization-induced host-gut microbial
metabolic interaction. MBio 2011, 2(2):e00271–10.
8. DuPont AW, DuPont HL: The intestinal microbiota and chronic disorders
of the gut. Nat Rev Gastroenterol Hepatol 2011, 8(9):523–531.
9. Clemente JC, Ursell LK, Parfrey LW, Knight R: The impact of the gut microbiota
on human health: an integrative view. Cell 2012, 148(6):1258–1270.
10. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R: Diversity,
stability and resilience of the human gut microbiota. Nature 2012,
489(7415):220–230.
11. Breton J, Le Clère K, Daniel C, Sauty M, Nakab L, Chassat T, Dewulf J,
Penet S, Carnoy C, Thomas P, et al: Chronic ingestion of cadmium and
lead alters the bioavailability of essential and heavy metals, gene
expression pathways and genotoxicity in mouse intestine. Arch Toxicol
2013, 87(10):1787–1795.
12. Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K:
Establishment of an analytical system for the human fecal microbiota,
based on reverse transcription-quantitative PCR targeting of multicopy
rRNA molecules. Appl Environ Microbiol 2009, 75(7):1961–1969.
13. Andersson AF, Riemann L, Bertilsson S: Pyrosequencing reveals contrasting
seasonal dynamics of taxa within Baltic Sea bacterioplankton
communities. ISME J 2010, 4(2):171–181.
14. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S,
Collini S, Pieraccini G, Lionetti P: Impact of diet in shaping gut microbiota
revealed by a comparative study in children from Europe and rural
Africa. Proc Natl Acad Sci U S A 2010, 107(33):14691–14696.
15. Yu Z, Morrison M: Comparisons of different hypervariable regions of rrs
genes for use in fingerprinting of microbial communities by PCR-denaturing
gradient gel electrophoresis. Appl Environ Microbiol 2004, 70(8):4800–4806.
16. Temmerman R, Scheirlinck I, Huys G, Swings J: Culture-independent
analysis of probiotic products by denaturing gradient gel electrophoresis.
Appl Environ Microbiol 2003, 69(1):220–226.
17. Vanhoutte T, Huys G, De Brandt E, Swings J: Temporal stability
analysis of the microbiota in human feces by denaturing gradient
gel electrophoresis using universal and group-specific 16S rRNA
gene primers. FEMS Microbiol Ecol 2004, 48(3):437–446.
18. Fazeli M, Hassanzadeh P, Alaei S: Cadmium chloride exhibits a profound
toxic effect on bacterial microflora of the mice gastrointestinal tract.
Hum Exp Toxicol 2011, 30(2):152–159.
19. Lepage P, Häsler R, Spehlmann ME, Rehman A, Zvirbliene A, Begun A, Ott S,
Kupcinskas L, Doré J, Raedler A, Schreiber S: Twin study indicates loss of
interaction between microbiota and mucosa of patients with ulcerative
colitis. Gastroenterology 2011, 141(1):227–236.
20. Brinkman BM, Hildebrand F, Kubica M, Goosens D, Del Favero J, Declercq W,
Raes J, Vandenabeele P: Caspase deficiency alters the murine gut
microbiome. Cell Death Dis 2011, 2:e220.
21. Berry D, Schwab C, Milinovich G, Reichert J, Ben Mahfoudh K, Decker T,
Engel M, Hai B, Hainzl E, Heider S, et al: Phylotype-level 16S rRNA analysis
reveals new bacterial indicators of health state in acute murine colitis.
ISME J 2012, 6(11):2091–2106.
22. Falk A, Olsson C, Ahrné S, Molin G, Adawi D, Jeppsson B: Ileal pelvic pouch
microbiota from two former ulcerative colitis patients, analysed by
DNA-based methods, were unstable over time and showed the presence
of Clostridium perfringens. Scand J Gastroenterol 2007, 42(8):973–985.
23. Bosshard PP, Zbinden R, Altwegg M: Turicibacter sanguinis gen. nov., sp.
nov., a novel anaerobic, Gram-positive bacterium. Int J Syst Evol Microbiol
2002, 52(Pt4):1263–1266.24. Werner T, Wagner SJ, Martínez I, Walter J, Chang JS, Clavel T, Kisling S,
Schuemann K, Haller D: Depletion of luminal iron alters the gut microbiota
and prevents Crohn’s disease-like ileitis. Gut 2011, 60(3):325–333.
25. Presley LL, Wei B, Braun J, Borneman J: Bacteria associated with
immunoregulatory cells in mice. Appl Environ Microbiol 2010,
76(3):936–941.
26. Po C, Klaassens ES, Durkin AS, Harkins DM, Foster L, McCorrison J, Torralba M,
Nelson KE, Morrison M: Draft genome sequence of Turicibacter sanguinis
PC909, isolated from human feces. J Bacteriol 2011, 193(5):1288–1289.
27. Upreti RK, Shrivastava R, Chaturvedi UC: Gut microflora & toxic metals:
chromium as a model. Indian J Med Res 2004, 119(2):49–59.
28. Lemon KP, Armitage GC, Relman DA, Fischbach MA: Microbiota-targeted
therapies: an ecological perspective. Sci Transl Med 2012, 4(137):137. rv5.
29. Quigley EM: Prebiotics and probiotics; modifying and mining the
microbiota. Pharmacol Res 2010, 61(3):213–218.
30. Breton J, Daniel C, Dewulf J, Pothion S, Froux N, Sauty M, Thomas P, Pot B,
Foligné B: Gut microbiota limits heavy metals burden caused by chronic
oral exposure. Toxicol Lett 2013, 222(2):132–138.
31. Rappaport SM, Smith MT: Epidemiology environment and disease risks.
Science 2010, 330(6003):460–461.
doi:10.1186/2050-6511-14-62
Cite this article as: Breton et al.: Ecotoxicology inside the gut: impact of
heavy metals on the mouse microbiome. BMC Pharmacology and
Toxicology 2013 14:62.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
